Clinical trial AMC303-01
A safety, tolerability and pharmacokinetic dose escalation expansion, Phase I/Ib study of AMC303 as monotherapy in patients with advanced or metastatic, malignant solid tumour of epithelial origin
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/1b |
| Academic trial | Non |
| Sponsor | Amcure GmbH |
| EudraCT Identifier | 2016-001358-16 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03009214 |
| Inclusion criteria | any line RECIST 1.1 |
| Last update |